Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4581 On Other Exchanges
Symbol
Exchange
4581 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Akira Uehara

Chairman, Chief Executive Officer and President, Taisho Pharmaceutical Holdings Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 2 different organizations across 3 different industries.

See Board Relationships
74¥121,000,000
As of Fiscal Year 2015

Background*

Mr. Akira Uehara serves as Chairman, Chief Executive Officer and President at Taisho Pharmaceutical Holdings Co., Ltd. Mr. Uehara serves as Chairman of Taisho Pharmaceutical Co., Ltd and has been its Director since June 26, 2015. Mr. Uehara serves as Representative Director of Taisho Pharmaceutical Holdings Co., Ltd. Mr. Uehara served as a Director of NEC Corp., since June 2002.

Corporate Headquarters*

3-24-1, Takada
Tokyo, -- 170-8655

Japan

Phone: 81 3 3985 2020
Fax: 81 3 3985 6485

Board Members Memberships*

Chairman, Chief Executive Officer and President
2002-N/A
Former Director
2015-Present
Chairman

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

Salary¥102,000,000
Total Annual Compensation¥102,000,000

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation¥102,000,000
Total Short Term Compensation¥102,000,000
Total Calculated Compensation¥121,000,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4581:JP ¥8,420.00 JPY +190.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Nick A. Caporella Chairman, Chief Executive Officer, Chairman of Nominating Committee and Chairman of Strategic Planning Committee
National Beverage Corp.
--
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
€6.6M
John Tobin Cahill Chairman and Chief Executive Officer
Kraft Foods Group, Inc.
$655.5K
Simon Litherland Chief Executive Officer and Director
Britvic Plc
1.1M GBP
Larry D. Young Chief Executive Officer, President, Director, Member of Capital Transaction Committee and Member of Special Award Committee
Dr Pepper Snapple Group, Inc.
$1.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TAISHO PHARMACEUTICAL HOLDIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.